← Back to Screener
NeuroOne Medical Technologies Corporation Common Stock (NMTC)
Price$4.98
Favorite Metrics
Price vs S&P 500 (26W)-23.83%
Price vs S&P 500 (4W)-6.07%
Market Capitalization$40.89M
All Metrics
Book Value / Share (Quarterly)$0.13
P/TBV (Annual)6.32x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)78.70%
Cash Flow / Share (Quarterly)$-0.12
Price vs S&P 500 (YTD)2.24%
Gross Margin (TTM)54.87%
Net Profit Margin (TTM)-78.34%
EPS (TTM)$-0.16
10-Day Avg Trading Volume0.07M
EPS Excl Extra (TTM)$-0.16
Revenue Growth (5Y)44.35%
EPS (Annual)$-0.09
ROI (Annual)-43.23%
Gross Margin (Annual)67.30%
Net Profit Margin (5Y Avg)-1069.60%
Cash / Share (Quarterly)$0.07
Revenue Growth QoQ (YoY)-53.90%
ROA (Last FY)-33.43%
Revenue Growth TTM (YoY)-0.38%
EBITD / Share (TTM)$-0.16
ROE (5Y Avg)-399.07%
Operating Margin (TTM)-87.71%
Cash Flow / Share (Annual)$-0.06
P/B Ratio6.39x
P/B Ratio (Quarterly)5.97x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)4.38x
Net Interest Coverage (TTM)-21.15x
ROA (TTM)-78.85%
EPS Incl Extra (Annual)$-0.09
Current Ratio (Annual)4.44x
Quick Ratio (Quarterly)4.96x
3-Month Avg Trading Volume0.05M
52-Week Price Return42.77%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.13
P/S Ratio (Annual)3.38x
Asset Turnover (Annual)1.12x
52-Week High$6.96
Operating Margin (5Y Avg)-1091.47%
EPS Excl Extra (Annual)$-0.09
CapEx CAGR (5Y)-7.39%
Tangible BV CAGR (5Y)29.76%
26-Week Price Return-15.09%
Quick Ratio (Annual)3.41x
13-Week Price Return-7.28%
Total Debt / Equity (Annual)0.18x
Current Ratio (Quarterly)6.41x
Enterprise Value$38.138
Revenue / Share Growth (5Y)-3.29%
Asset Turnover (TTM)1.01x
Book Value / Share Growth (5Y)-12.78%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.63x
Pretax Margin (Annual)-29.80%
Cash / Share (Annual)$0.13
3-Month Return Std Dev81.75%
Gross Margin (5Y Avg)46.27%
Net Income / Employee (TTM)$-0
ROE (Last FY)-50.98%
Net Interest Coverage (Annual)-4.14x
EPS Basic Excl Extra (Annual)$-0.09
P/FCF (TTM)215.22x
Receivables Turnover (TTM)3.47x
Total Debt / Equity (Quarterly)0.13x
EPS Incl Extra (TTM)$-0.16
Receivables Turnover (Annual)16.79x
ROI (TTM)-100.23%
P/S Ratio (TTM)4.69x
Pretax Margin (5Y Avg)-1069.60%
Revenue / Share (Annual)$0.30
Tangible BV / Share (Annual)$0.14
Price vs S&P 500 (52W)7.68%
Year-to-Date Return6.37%
5-Day Price Return7.56%
EPS Normalized (Annual)$-0.09
ROA (5Y Avg)-122.52%
Net Profit Margin (Annual)-29.80%
Month-to-Date Return3.86%
Cash Flow / Share (TTM)$-0.60
EBITD / Share (Annual)$-0.09
Operating Margin (Annual)-34.94%
LT Debt / Equity (Annual)0.18x
ROI (5Y Avg)-180.98%
LT Debt / Equity (Quarterly)0.13x
EPS Basic Excl Extra (TTM)$-0.16
P/TBV (Quarterly)6.01x
P/B Ratio (Annual)6.28x
Inventory Turnover (TTM)2.19x
Pretax Margin (TTM)-78.34%
Book Value / Share (Annual)$0.14
Price vs S&P 500 (13W)-10.14%
Beta0.64x
Revenue / Share (TTM)$0.17
ROE (TTM)-119.92%
52-Week Low$3.00
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.25
4.25
4.25
4.22
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
NMTCNeuroOne Medical Technologies Corporation Common Stock | 4.69x | 44.35% | 54.87% | -87.71% | $4.98 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
NeuroOne Medical Technologies develops thin film electrode technology for diagnostic, therapeutic, and monitoring applications in neurology, focusing on epilepsy, Parkinson's disease, and pain management. The company commercializes products including the Evo Cortical, Evo sEEG, and OneRF Ablation System for brain recording, stimulation, and ablation.